CTOR Competitors & Alternatives

Compare Citius Oncology, Inc. with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

CTOR

Main Stock
$0.91
Tradestie Score
62
Market Cap
$164.52M
Analyst Upside
+561.7%

Top Competitors

49 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 57 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$29.65
$543.32M - 60 Compare
CGC Canopy Growth Corporation Common Shares
$1.11
$430.55M - 54 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.22
$237.15M 6.7 53 Compare
BIOA BioAge Labs, Inc. Common Stock
$17.99
$212.23M - 54 Compare
SLXN Silexion Therapeutics Corp Ordinary Shares
$0.53
$11.85M - 54 Compare
DEVS DevvStream Corp. Common Stock
$0.16
$9.95M - 46 Compare
IBO Impact BioMedical, Inc.
$0.63
$7.84M - 57 Compare
PLRZ Polyrizon Ltd. Ordinary Shares
$16.34
$6.53M - 59 Compare
NIVF NewGenIvf Group Limited Class A ordinary shares
$1.21
$4.04M 0.0 54 Compare

Data updated: May 09, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

49 stocks in this industry